Prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure on brain development, cognition and activity related risk for obesity: A longitudinal study with 10 year olds
Principal Investigator:
- Sarah Hutchison, University of British Columbia
- University of British Columbia
Project Overview
Dr. Hutchison‘s training is in lifespan psychology and her research broadly focuses on children’s cognitive and social development. her current research project examines cognitive and health outcomes in children whose mothers’ were treated with antidepressant medication during pregnancy. About 10- 20% of women experience depressed mood during pregnancy and Serotonin Reuptake Inhibitors are the most prevalent medication for treating maternal mood disorders during pregnancy. This is an exciting contribution to this field of study because not much is known about the long term impact of prenatal SRI exposure on children’s cognition and health.
